@nazliokumusmd.bsky.social
Interventional/Structural Cardiologist at CVI CFl
CardioNerds IC Council Chair
CircAHA SoMe editor
SCAI_WIN
SCAI PAC
NCDR CATHPCI
CardioNerds IC Council Chair
CircAHA SoMe editor
SCAI_WIN
SCAI PAC
NCDR CATHPCI
3/ At 3 years:
🫀Similar rates of structural valve deterioration (≥moderate) 4.5% TAVR vs 5.2% surgery;
🫀Lower rates of bioprosthetic valve dysfunction with TAVR (11.9% vs. 21%);
🫀Similar rates of bioprosthetic valve failure (1.6% vs 2.9%).
🫀Similar rates of structural valve deterioration (≥moderate) 4.5% TAVR vs 5.2% surgery;
🫀Lower rates of bioprosthetic valve dysfunction with TAVR (11.9% vs. 21%);
🫀Similar rates of bioprosthetic valve failure (1.6% vs 2.9%).
August 30, 2025 at 4:20 PM
3/ At 3 years:
🫀Similar rates of structural valve deterioration (≥moderate) 4.5% TAVR vs 5.2% surgery;
🫀Lower rates of bioprosthetic valve dysfunction with TAVR (11.9% vs. 21%);
🫀Similar rates of bioprosthetic valve failure (1.6% vs 2.9%).
🫀Similar rates of structural valve deterioration (≥moderate) 4.5% TAVR vs 5.2% surgery;
🫀Lower rates of bioprosthetic valve dysfunction with TAVR (11.9% vs. 21%);
🫀Similar rates of bioprosthetic valve failure (1.6% vs 2.9%).
2/
🫀Primary composite (death, stroke or valve/procedure/HF related hospitalization): 16.1% TAVR vs 12.6% surgery -> no significant difference.
🫀In bicuspid valve patients, outcomes favored surgery, though not statistically significant. #SoMeEditor #CardioTwitter #TAVR
🫀Primary composite (death, stroke or valve/procedure/HF related hospitalization): 16.1% TAVR vs 12.6% surgery -> no significant difference.
🫀In bicuspid valve patients, outcomes favored surgery, though not statistically significant. #SoMeEditor #CardioTwitter #TAVR
August 30, 2025 at 4:20 PM
2/
🫀Primary composite (death, stroke or valve/procedure/HF related hospitalization): 16.1% TAVR vs 12.6% surgery -> no significant difference.
🫀In bicuspid valve patients, outcomes favored surgery, though not statistically significant. #SoMeEditor #CardioTwitter #TAVR
🫀Primary composite (death, stroke or valve/procedure/HF related hospitalization): 16.1% TAVR vs 12.6% surgery -> no significant difference.
🫀In bicuspid valve patients, outcomes favored surgery, though not statistically significant. #SoMeEditor #CardioTwitter #TAVR
🚀 Excited to be an official #SoMe Ambassador for #SCAI2025! Join me
May 1–3 in Washington, D.C. for cutting-edge education, networking, and
innovation in #InterventionalCardiology. Follow along for live updates! 🔗
scai.org/scai2025 #SCAI @scainews.bsky.social #CardioSky
May 1–3 in Washington, D.C. for cutting-edge education, networking, and
innovation in #InterventionalCardiology. Follow along for live updates! 🔗
scai.org/scai2025 #SCAI @scainews.bsky.social #CardioSky
April 8, 2025 at 11:07 PM
🚀 Excited to be an official #SoMe Ambassador for #SCAI2025! Join me
May 1–3 in Washington, D.C. for cutting-edge education, networking, and
innovation in #InterventionalCardiology. Follow along for live updates! 🔗
scai.org/scai2025 #SCAI @scainews.bsky.social #CardioSky
May 1–3 in Washington, D.C. for cutting-edge education, networking, and
innovation in #InterventionalCardiology. Follow along for live updates! 🔗
scai.org/scai2025 #SCAI @scainews.bsky.social #CardioSky